PharmacoEconomics & Outcomes News

, Volume 527, Issue 1, pp 9–9 | Cite as

Admin route for chemo has little impact on QOL

Clinical study


Ovarian Cancer Paclitaxel Ovarian Cancer Patient Folinic Acid Intraperitoneal Chemotherapy 


  1. 1.
    Kopec JA, Yothers G, Ganz PA, Land SR, Cecchini RS, Wieand HS, Lembersky BC, Wolmark N.Quality of life in operable colon cancer patients receiving oral compared with intravenous chemotherapy: results from National Surgical Adjuvant Breast and Bowel Project Trial C-06. Journal of Clinical Oncology 25: 424-430, No. 4, 1 Feb 2007Google Scholar
  2. 2.
    Wenzel LB, Huang HQ, Armstrong DK, Walker JL, Cella D.Health-related quality of life during and after intraperitoneal versus intravenous chemotherapy for optimally debulked ovarian cancer: a Gynecologic Oncology Group Study. Journal of Clinical Oncology 25: 437-443, No. 4, 1 Feb 2007Google Scholar

Copyright information

© Adis International Ltd 2007

Personalised recommendations